<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center In the News

OncLive

Dr. Schenk on the Evolving Treatment Landscape in Lung Cancer

news outletOncLive
Publish DateAugust 25, 2020

Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.

Full Story
OncLive

Dr. Bunn on Targeting HER3 in NSCLC

news outletOncLive
Publish DateAugust 18, 2020

Paul A. Bunn, Jr, MD, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado, and a 2014 Giant of Cancer Care® in Lung Cancer, discusses potentially targeting HER3 in non–small cell lung cancer (NSCLC).

Full Story
Oncology Learning Network

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

news outletOncology Learning Network
Publish DateAugust 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.

Full Story
OncLive

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

news outletOncLive
Publish DateJuly 27, 2020

Paul A. Bunn, Jr, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado and a 2014 Giant of Cancer Care® in Lung Cancer, highlights encouraging data with fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-mutant non–small cell lung cancer (NSCLC).

Full Story
Healio

Fewer children enrolling in cancer clinical trials, study shows

news outletHealio
Publish DateJuly 02, 2020

According to Kelly Faulk, University of Colorado Cancer Center investigator and pediatric oncologist at Children’s Hospital Colorado, these findings are not altogether negative. “Good treatments have been developed for some of our most common childhood cancers, such as acute lymphoblastic leukemia,” Faulk said in an interview with Healio.

Full Story
9News

Colorado fitness center helps to build up cancer survivors

news outlet9News
Publish DateJune 10, 2020

On the CU Anschutz Medical Campus, there’s a factory known to churn out warriors, a fitness center just for patients battling cancer.

Full Story
MedPage Today

SRS for Brain Metastases in Small Cell Lung Cancer?

news outletMedPage Today
Publish DateJune 08, 2020

According to a study lead by Chad Rusthoven, MD, patients with small cell lung cancer (SCLC) with brain metastases saw similar if not slightly better survival when treated with stereotactic radiosurgery (SRS) compared with standard-of-care whole brain radiotherapy (WBRT).

Full Story
MedPage Today

Potential New Standard for High-Risk, Pediatric B-Cell Lymphoma

news outletMedPage Today
Publish DateJune 05, 2020

“These outstanding results support rituximab as a new standard-of-care therapy for young patients with advanced B-cell non-Hodgkin lymphoma,” co-author Thomas Gross, of University of Colorado Cancer Center and Children’s Hospital Colorado, said.

Full Story
Medscape

Lung Cancer in the Time of COVID-19

news outletMedscape
Publish DateJune 02, 2020

Lung cancer is the leading cause of cancer deaths worldwide, and metastatic non–small cell lung cancer (NSCLC) is the deadliest form, with a 5-year survival rate of just over 5%. Nonetheless, thoracic oncologists at the University of Colorado Cancer Center in Aurora who specialize in the treatment of advanced NSCLC say there is room for optimism. In this six-part series, distinguished professor Paul Bunn and his colleagues Ross Camidge and Erin Schenk discuss how to choose the optimal treatment for a patient on the basis of pathologic findings, disease staging, and biomarker testing.

Full Story
CBS4 Denver

Colorado Sunshine Does No Favors For Skin Health

news outletCBS4 Denver
Publish DateMay 19, 2020

“Colorado has some of the highest UV exposure levels in the country,” Dr. Neil Box of the University of Colorado’s Cancer Center said during an interview on CBSN Denver. “Melanoma is historically the most dangerous form of cancer,” adding basal cell and squamous carcinoma are the most common types of skin cancer.

Full Story